Clinical Trial Update: FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating FDG-PET/CT versus conventional CT for monitoring metastatic breast cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Odense University Hospital | Conditions: Metastatic Breast Cancer, Response Monitoring | NA | Status: RECRUITING